Canaccord Genuity reaffirmed their hold rating on shares of LivaNova PLC (NASDAQ:LIVN) in a research report sent to investors on Tuesday morning. They currently have a $76.00 price objective on the stock.

“We stay HOLD rated on LIVN coming out of constructive meetings with management on the road last week. We continue to believe the firm possesses intriguing long-term growth initiatives –in transcatheter mitral valve replacement (TMVR), heart failure (HF) and treatment-resistant depression (TRD) – but anticipate these segments will take several years to materialize and likely require additional M&A and material R&D spending before either the TMVR or HF initiatives could potentially contribute to LIVN’s top- and bottom-line growth profiles. That said, we sensed incrementally stronger conviction from management regarding both robust GM expansion potential as well as low-DD revenue growth from the emerging markets (ROW) business. Taken together, we management seems confident it can deliver merger integration cost synergies that the think these drivers could help the firm hit or exceed its guidance in 4Q:17.”,” the firm’s analyst wrote.

Several other analysts have also recently commented on LIVN. BTIG Research reaffirmed a hold rating on shares of LivaNova PLC in a research report on Tuesday, November 7th. Berenberg Bank reaffirmed a buy rating and issued a $70.00 target price on shares of LivaNova PLC in a research report on Friday, August 11th. Needham & Company LLC began coverage on LivaNova PLC in a research report on Wednesday, August 23rd. They issued a hold rating for the company. Zacks Investment Research raised LivaNova PLC from a hold rating to a buy rating and set a $89.00 target price for the company in a research report on Thursday, November 9th. Finally, WBB Securities cut LivaNova PLC from a hold rating to a sell rating and set a $50.00 target price for the company. in a research report on Tuesday, August 15th. One analyst has rated the stock with a sell rating, three have assigned a hold rating and six have given a buy rating to the stock. The company has a consensus rating of Buy and a consensus price target of $78.57.

Shares of LivaNova PLC (LIVN) traded up $0.96 during midday trading on Tuesday, hitting $82.04. The company had a trading volume of 270,100 shares, compared to its average volume of 392,540. The company has a quick ratio of 1.42, a current ratio of 2.03 and a debt-to-equity ratio of 0.04. The firm has a market cap of $3,908.99, a PE ratio of 23.37, a price-to-earnings-growth ratio of 2.43 and a beta of 0.52. LivaNova PLC has a twelve month low of $40.83 and a twelve month high of $82.12.

LivaNova PLC (NASDAQ:LIVN) last issued its earnings results on Thursday, November 2nd. The company reported $0.93 earnings per share (EPS) for the quarter, topping the Zacks’ consensus estimate of $0.76 by $0.17. The business had revenue of $309.70 million for the quarter, compared to analysts’ expectations of $301.22 million. LivaNova PLC had a return on equity of 9.33% and a net margin of 4.63%. The company’s quarterly revenue was up 4.9% on a year-over-year basis. During the same period in the previous year, the firm posted $0.78 EPS. sell-side analysts expect that LivaNova PLC will post 3.33 EPS for the current year.

COPYRIGHT VIOLATION WARNING: “LivaNova PLC (LIVN) Given Hold Rating at Canaccord Genuity” was published by Watch List News and is the sole property of of Watch List News. If you are accessing this news story on another site, it was copied illegally and republished in violation of United States & international copyright law. The original version of this news story can be viewed at https://www.watchlistnews.com/livanova-plc-livn-given-hold-rating-at-canaccord-genuity/1705644.html.

In related news, Director Daniel Jeffrey Moore sold 1,000 shares of LivaNova PLC stock in a transaction on Monday, October 16th. The stock was sold at an average price of $74.58, for a total transaction of $74,580.00. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this hyperlink. 0.28% of the stock is currently owned by company insiders.

A number of institutional investors and hedge funds have recently added to or reduced their stakes in the stock. California Public Employees Retirement System boosted its position in LivaNova PLC by 2.5% during the third quarter. California Public Employees Retirement System now owns 149,307 shares of the company’s stock valued at $10,460,000 after purchasing an additional 3,641 shares during the last quarter. Janney Montgomery Scott LLC lifted its position in shares of LivaNova PLC by 248.7% in the third quarter. Janney Montgomery Scott LLC now owns 12,916 shares of the company’s stock worth $905,000 after buying an additional 9,212 shares during the last quarter. Jane Street Group LLC acquired a new stake in shares of LivaNova PLC in the third quarter worth about $611,000. PEAK6 Investments L.P. lifted its position in shares of LivaNova PLC by 349.5% in the third quarter. PEAK6 Investments L.P. now owns 30,414 shares of the company’s stock worth $2,131,000 after buying an additional 23,648 shares during the last quarter. Finally, NWQ Investment Management Company LLC lifted its position in shares of LivaNova PLC by 71.2% in the third quarter. NWQ Investment Management Company LLC now owns 500,594 shares of the company’s stock worth $35,072,000 after buying an additional 208,264 shares during the last quarter. 82.20% of the stock is owned by hedge funds and other institutional investors.

LivaNova PLC Company Profile

LivaNova PLC is a medical device company focused on the development and delivery of therapeutic solutions. The Company’s segments include Cardiac Surgery, Cardiac Rhythm Management, Neuromodulation and Other. The Cardiac Surgery segment is engaged in the development, production and sale of cardiovascular surgery products.

Analyst Recommendations for LivaNova PLC (NASDAQ:LIVN)

Receive News & Ratings for LivaNova PLC Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for LivaNova PLC and related companies with Analyst Ratings Network's FREE daily email newsletter.